5HENRIQUES J P , ZIJLSTRA F, OTTERVANGER J P, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction [J]. Eur Heart, 2002, 23: 1112 - 1117.
6BARCIN C, DENKTAS A E,GARRATT K N,et al. Relation of thrombolysis in myocardial infarction (TIMI) frame count to coronary flow parameters [J]. Am J Gardiol, 2003,91 : 466- 469.
7TSVETKOV H, MOSSERI M. Myocardial blush grade: an interventional method for assessing myocardial perfusion[J]. Isr Med Assoc J, 2008,10:465- 467.
8ABE Y, MURO T , SAKANOUE Y,et al . Intravenous myocardial contrast echocardiography predict s regional and global left ventricular remodeling after acute myocardial infarction: Comparison with dose dobutamine stress echocardiography[J]. Heart,2005, 91 : 1578- 1583.
9VAN'T HOF A W, LIEM A, SURYAPRANATA H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade[J]. Circulation, 1998,97 : 2302-2306.
10LEFEVRE T, GARCIA E, REIMERS B, et al. X- sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial [J]. J Am Coll Cardiol, 2005,46:246-252.
1Wang HL, Xing SY, Dong PS, et al. Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention[J]. European review for medical and pharmacological sci- ences, 2014, 18(23):3690-3695.
2Wang K, Zuo G, Zheng L, et al. Effects of tirofiban on platelet activa- tion and endothelial function in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Cell biochemistry and biophysics,2015, 71( 1 ): 135-142.
3Tanguay JF, Bell AD, Ackman ML, et al .Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy[J].The Canadian journal of cardiology,2013,29( 11 ): 1334-1345.
4Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarc- tion after 1 year in the Thrombus Aspiration during Percutaneous coro- nary intervention in Acute myocardial infarction Study (TAPAS): a l- year follow-up study[J]. Lancet (London, England), 2008, 371(9628):1915-1920.
5Gu YL, Kampinga MA, Wieringa WG, et al. Intracoronary versus intra- venous administration of abciximab in patients with ST-segment eleva- tion myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfu-sion of ST-segment elevation myocardial infarction (CICERO) trial[J]. Circulation, 2010, 122(25):2709-2717.
6Akpek M, Sahin O, Sarli B, et al.Acute Effects of Intracoronary Tirofi- ban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary In- tervention[J]. Angiology, 2015,66(6):560-567.
